Back to Journals » OncoTargets and Therapy » Volume 14

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

Total article views   HTML views PDF downloads Totals
5,796 Dovepress* 4,696+ 205 4,901
PubMed Central* 1,100 337 1,437
Totals 5,796 542 6,338
*Since 18 November 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar